{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-100455","form_type":"8-K","ticker":"TRAW","cik":"0001130598","company_name":"Traws Pharma, Inc.","filed_at":"2025-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.858460+00:00","generated_at":"2026-05-17T03:21:10.882731+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Traws Pharma grants 184,492 stock options to five executive officers at $3.01 strike","bullets":["CEO Iain Dukes: 64,839 options; CFO Parker, CSO Pauza, CMO Redfield each 32,406; COO Savchuk 22,435.","Exercise price $3.01/share (Oct 10 closing); 10-year term; full vest on first anniversary (Oct 12, 2026).","Granted under Amended and Restated 2021 Incentive Compensation Plan; subject to continued service."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-100455","json":"https://secwatch.observer/filing/0001104659-25-100455.json","markdown":"https://secwatch.observer/filing/0001104659-25-100455.md","text":"https://secwatch.observer/filing/0001104659-25-100455.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1130598/000110465925100455/0001104659-25-100455-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1130598/000110465925100455/tm2528641d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:21:10.882731+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}